WASHINGTON (Reuters) – The Obama administration has delayed a step crucial to the launch of the new healthcare law, the signing of final agreements with insurance plans to be sold on federal health insurance exchanges starting October 1.
The U.S. Department of Health and Human Services (HHS) notified insurance companies on Tuesday that it would not sign final agreements with the plans between September 5 and 9, as originally anticipated, but would wait until mid-September instead, according to insurance industry sources.
(Reuters) – Aetna Inc pulled out of Maryland’s health insurance exchange being created under President Barack Obama’s healthcare reform law after the state pressed it to lower its proposed rates by up to 29 percent.
Under the law, often called Obamacare, each U.S. state will have an online exchange where Americans will be able to buy insurance plans, starting on October 1. The government is counting on about 7 million people to enroll next year for this insurance, many of whom will qualify for subsidies.
NEW YORK (Reuters) – With the October 1 date for enrollment in the health insurance exchanges being created by Obamacare less than two months away, a war of numbers has been escalating.
Health insurance will cost way less. Or it will cost way more. It depends who you ask.
NEW YORK, Aug 2 (Reuters) – With the Oct. 1 date for
enrollment in the health insurance exchanges being created by
Obamacare less than two months away, a war of numbers has been
Health insurance will cost way less. Or it will cost way
more. It depends who you ask.
(Reuters) – Cigna Corp, which provides U.S. and overseas health insurance as well as disability and life insurance, reported a second-quarter profit that beat expectations on Thursday as medical costs fell and revenue rose.
A weaker U.S. economy has forced people to cut back on medical services in the past few years, reducing insurers’ payments on claims. Companies like UnitedHealth Group Inc, WellPoint Inc, and Aetna Inc have beaten expectations for the quarter because of this trend.
(Reuters) – Health insurer Humana Inc said on Wednesday that its second-quarter profit rose 18 percent, helped by low medical costs and growth in both its direct-to-customer division and employer-based insurance unit.
Chief Executive Officer Bruce Broussard said while government cutbacks to private Medicare plans for the elderly planned for 2014 were ‘onerous’, he still anticipates growth in sales of these plans directly to individuals.
(Reuters) – Florida and Georgia, two states where politicians oppose U.S. President Barack Obama’s healthcare law, said on Tuesday that insurance rates for individuals would rise sharply in 2014 under the reform.
The remarks are part of an increasingly polarized debate over whether “Obamacare” will prove affordable for millions of uninsured Americans when new health plans become available on state-based exchanges as of October 1.
(Reuters) – U.S. health insurer Aetna Inc reported higher quarterly profits on Tuesday as medical costs in its employer-based and commercial business remained low and it closed on its acquisition of Coventry Health Care.
Aetna Chief Executive Mark Bertolini said he was “increasingly confident” the company would have higher operating earnings in 2014, but warned that Aetna expects lower growth in private Medicare, where the government has cut spending.
(Reuters) – U.S. hospital chain Community Health Systems Inc (CYH.N: Quote, Profile, Research, Stock Buzz) said on Tuesday it would buy smaller Health Management Associates Inc (HMA.N: Quote, Profile, Research, Stock Buzz) for $3.9 billion to increase its base during the overhaul of the country’s healthcare system.
Health Management on Tuesday also disclosed it had received additional subpoenas in a widening federal government investigation of its admissions practices. The troubled company also named a new CEO on Tuesday.
July 25 (Reuters) – Boston Scientific Corp on
Thursday reported its first quarter of operating revenue growth
in years and beat analyst expectations for second-quarter
profit, pushing up shares to their highest level in nearly four
Like many medical devicemakers, Boston Scientific has
struggled with weak sales for the last several years as U.S.
consumers lost their jobs and health insurance, leading them to
delay medical procedures. Demand also fell as governments around
the world cut spending on healthcare.